These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 26716915)
1. Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer. Lin SH; Zhang N; Godby J; Wang J; Marsh GD; Liao Z; Komaki R; Ho L; Hofstetter WL; Swisher SG; Mehran RJ; Buchholz TA; Elting LS; Giordano SH Cancer; 2016 Mar; 122(6):917-28. PubMed ID: 26716915 [TBL] [Abstract][Full Text] [Related]
2. Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancer. Lin SH; Wang L; Myles B; Thall PF; Hofstetter WL; Swisher SG; Ajani JA; Cox JD; Komaki R; Liao Z Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1078-85. PubMed ID: 22867894 [TBL] [Abstract][Full Text] [Related]
3. Comparing Risk for Second Primary Cancers After Intensity-Modulated vs 3-Dimensional Conformal Radiation Therapy for Prostate Cancer, 2002-2015. Pithadia KJ; Advani PG; Citrin DE; Bekelman JE; Withrow DR; Berrington de Gonzalez A; Morton LM; Schonfeld SJ JAMA Oncol; 2023 Aug; 9(8):1119-1123. PubMed ID: 37289449 [TBL] [Abstract][Full Text] [Related]
4. Cost of Intensity-modulated Radiation Therapy for Older Patients with Stage III Lung Cancer. Kale MS; Mhango G; Bonomi M; Federman A; Sigel K; Rosenzweig KE; Wisnivesky JP Ann Am Thorac Soc; 2016 Sep; 13(9):1593-9. PubMed ID: 27299697 [TBL] [Abstract][Full Text] [Related]
5. A population-based comparative effectiveness study of radiation therapy techniques in stage III non-small cell lung cancer. Harris JP; Murphy JD; Hanlon AL; Le QT; Loo BW; Diehn M Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):872-84. PubMed ID: 24495591 [TBL] [Abstract][Full Text] [Related]
6. Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis. Satkunasivam R; Kim AE; Desai M; Nguyen MM; Quinn DI; Ballas L; Lewinger JP; Stern MC; Hamilton AS; Aron M; Gill IS J Urol; 2015 Aug; 194(2):378-85. PubMed ID: 25711194 [TBL] [Abstract][Full Text] [Related]
7. Outcomes after intensity-modulated versus conformal radiotherapy in older men with nonmetastatic prostate cancer. Bekelman JE; Mitra N; Efstathiou J; Liao K; Sunderland R; Yeboa DN; Armstrong K Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e325-34. PubMed ID: 21498008 [TBL] [Abstract][Full Text] [Related]
9. Predictors of IMRT and conformal radiotherapy use in head and neck squamous cell carcinoma: a SEER-Medicare analysis. Sher DJ; Neville BA; Chen AB; Schrag D Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e197-206. PubMed ID: 21596483 [TBL] [Abstract][Full Text] [Related]
10. Propensity score-based comparison of survival and radiation pneumonitis after definitive chemoradiation for esophageal cancer: Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy. Lan K; Zhu J; Zhang J; Zhou S; Yang Y; Feng Z; Zhang L; Wang S; Xi M Radiother Oncol; 2020 Aug; 149():228-235. PubMed ID: 32474127 [TBL] [Abstract][Full Text] [Related]
11. Improved survival using intensity-modulated radiation therapy in head and neck cancers: a SEER-Medicare analysis. Beadle BM; Liao KP; Elting LS; Buchholz TA; Ang KK; Garden AS; Guadagnolo BA Cancer; 2014 Mar; 120(5):702-10. PubMed ID: 24421077 [TBL] [Abstract][Full Text] [Related]
12. The Impact of Intensity Modulated Radiation Therapy on Hospitalization Outcomes in the SEER-Medicare Population With Anal Squamous Cell Carcinoma. Pollom EL; Wang G; Harris JP; Koong AC; Bendavid E; Bhattacharya J; Chang DT Int J Radiat Oncol Biol Phys; 2017 May; 98(1):177-185. PubMed ID: 28258896 [TBL] [Abstract][Full Text] [Related]
13. Comparative effectiveness of intensity-modulated versus 3D conformal radiation therapy among medicare patients with stage III lung cancer. Chen AB; Li L; Cronin A; Schrag D J Thorac Oncol; 2014 Dec; 9(12):1788-95. PubMed ID: 25226428 [TBL] [Abstract][Full Text] [Related]
14. Reduced feeding tube duration with intensity-modulated radiation therapy for head and neck cancer: A Surveillance, Epidemiology, and End Results-Medicare Analysis. Beadle BM; Liao KP; Giordano SH; Garden AS; Hutcheson KA; Lai SY; Guadagnolo BA Cancer; 2017 Jan; 123(2):283-293. PubMed ID: 27662641 [TBL] [Abstract][Full Text] [Related]
16. Clinical results of definitive chemoradiotherapy for cervical esophageal cancer: Comparison of failure pattern and toxicities between intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy. Ito M; Kodaira T; Tachibana H; Tomita N; Makita C; Koide Y; Kato D; Abe T; Muro K; Tajika M; Niwa Y; Hasegawa Y Head Neck; 2017 Dec; 39(12):2406-2415. PubMed ID: 28960561 [TBL] [Abstract][Full Text] [Related]
17. Comparison of three-dimensional conformal radiation therapy, intensity-modulated radiation therapy, and volumetric-modulated arc therapy in the treatment of cervical esophageal carcinoma. Yang H; Feng C; Cai BN; Yang J; Liu HX; Ma L Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 27629865 [TBL] [Abstract][Full Text] [Related]
18. Intensity-Modulated Radiation Therapy May Improve Local-Regional Tumor Control for Locally Advanced Non-Small Cell Lung Cancer Compared With Three-Dimensional Conformal Radiation Therapy. Wang J; Zhou Z; Liang J; Feng Q; Xiao Z; Hui Z; Wang X; Lv J; Chen D; Zhang H; Ji Z; Cao J; Liu L; Jiang W; Men Y; Xu C; Dai J; Yin W; Wang L Oncologist; 2016 Dec; 21(12):1530-1537. PubMed ID: 27628491 [TBL] [Abstract][Full Text] [Related]
19. Outcomes between intensity-modulated radiation therapy versus 3D-conformal in early stage glottic cancer. Amini A; Morgan R; Meyer E; Fakhoury K; Ladbury C; Bickett T; McDermott JD; Stokes W; Karam SD Head Neck; 2021 Nov; 43(11):3393-3403. PubMed ID: 34382714 [TBL] [Abstract][Full Text] [Related]
20. Late Side Effects After Image Guided Intensity Modulated Radiation Therapy Compared to 3D-Conformal Radiation Therapy for Prostate Cancer: Results From 2 Prospective Cohorts. Wortel RC; Incrocci L; Pos FJ; van der Heide UA; Lebesque JV; Aluwini S; Witte MG; Heemsbergen WD Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):680-9. PubMed ID: 27055398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]